echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Professor Chen Shunle, one of the founders of rheumatology in China, has died

    Professor Chen Shunle, one of the founders of rheumatology in China, has died

    • Last Update: 2021-01-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    SHANGHAI, Jan. 23 (Xinhua Chen Jing) One of the founders of rheumatology in China, professor Chen Shunle, known internationally as "the father of lupus in China", died at 0:30 on the 23rd at the age of 89.
    In the motherland medicine, systemic lupus erythematosus (SLE) is called "butterfly disease", Professor Chen Shunle hoped that his patients, like a beautiful butterfly, break free of the shackles of disease, in their own lives to fly.
    Professor Chen Shunle, born in February 1932, is the founder of the rheumatology department of Renji Hospital, affiliated with Shanghai Jiaoxuan University School of Medicine, and the Shanghai Institute of Rheumatology, which has presided over the establishment of China's largest genetic database of the core family of lupus, and the creation of a combination of immunosuppressants to improve efficacy while reducing side effects. He has been awarded the Master of the American Rheumatology Institute and the Asia Pacific Rheumatology Alliance Master Award.
    Huangpu River, 145 Zhonglu, Shandong Province, now Renji Hospital West Hospital has a brick-red building that has experienced more than 80 years of wind and rain, where Chen Shunle has worked for half a century.
    Chen Shunle chose systemic lupus erythematosus (SLE) as the main direction of rheumatology. This is an autoimmune disease that can affect multiple organs throughout the body, with complex lesions, difficulty in treatment and extremely high mortality rates. At that time, there was no epidemiological investigation of SLE incidence in China. It is generally accepted Chinese the prevalence of lupus in the united States is high and serious.
    Established a laboratory testing platform for autoimmune diseases, and through independent research and development, established relevant testing technology in China, so that the diagnosis of SLE can be based on. Subsequently, he conducted a large-scale epidemiological survey of 32,668 Textile Workers in Shanghai and found that the prevalence rate of SLE in China was 70 per 100,000 and 113 per 100,000 in women. The findings were written into chinese medical students' textbooks and caught the world's eye.
    in the treatment, Chen Shunle found that although high-dose hormones are beneficial to control the disease, but bring many side effects, drug-induced complications greatly affect the quality of life of patients. His innovative treatment options have become a classic treatment for SLE patients, greatly improving survival rates and allowing many patients to live and work normally.
    Chen Shunle held several national courses to promote the laboratory diagnosis technology of rheumatism and improve the level of diagnosis of rheumatism in China. In 1988, he formulated the diagnostic standard of SLE in China, after the verification of 27 medical units in the country, confirmed that compared with the 1982 ARA standard in the United States, more conducive to the early diagnosis of SLE, was adopted as a national standard, included in the textbooks of medical colleges and universities.
    the 1990s, when molecular genetics research was just making waves internationally, Professor Chen Shunle's research team became the first in China to engage in rheumatology genetics research.
    Gynecology, Radiology, Orthopaedics, Pediatrics, Endocrinology and Cardiology are the most closely linked departments in rheumatology, and Chen Shunle has formed gropec cooperation, hoping to promote the development of rheumatology and the development of various disciplines through interdisciplinary collaboration.
    it is understood that in the past lupus treatment process, pregnancy is considered to aggravate the disease, doctors generally do not recommend the patient to give birth, which increases the psychological burden and pain of patients. Rheumatology and obstetrics and gynecology join hands, after continuous efforts and efforts, finally achieved a breakthrough of zero: in 1992, the first SLE patient's baby fell to the ground. Since then, SLE has ceased to be a no-go zone for fertility. Chen Shunle also summarized and put forward the standard of pre-pregnancy disease relief for SLE patients, which provides reference for clinicians' treatment decision-making.
    , a discipline leader in the rheumatology department of the PLA General Hospital, was a participant in the 1991 Shanghai International Rheumatology New Progress Course organized by Chen Shunle and WHO. He said in an interview: "Professor Chen not only high-rise building in his own department to carry out cutting-edge research in line with international standards, but also for the national popularization of basic and clinical immunology, clinical rheumatology knowledge to work hard ... It opens the window to the world of rheumatology abroad and builds a platform for the younger generation of rheumatology scholars in our country to connect with the world. It
    Chen Shunle's dream to give patients not only the same life as healthy people, but also the ability to be beautiful and compete in society. At the beginning of his career, he proposed the establishment of a database of patients with sustainable rheumatology.
    from the original hand-drawn follow-up table to the present electronic database; A single document documents each onset and remission of the patient, and a chart reveals the pathogenesis and pathogenesis of the disease.
    it is learned that on the occasion of the 50th anniversary of Professor Chen Shunle's medical treatment,
    Zhong Nanshan of the Chinese Academy of Engineering waved his words: "Qingyun is white and neon, and shoot Sirius with a long target." ”
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.